Financial Results and Corporate Presentation Materials

Performance Overview

The Kanamic Group is driving growth across three pillars. For the fiscal year ending September 2026, it recorded revenue of 6,164 million yen, EBITDA of 2,510 million yen, operating income of 205.7 million yen, and net income of 144.8 million yen, all reaching record highs. By segment, the Medical & Nursing Care Cloud Platform and Healthy Life Extension businesses led performance. Introduction of new AI-integrated features and network/store expansion supported growth, and further revenue and profit increases are expected in the coming fiscal year.

Outlook, Dividends and Investor Returns

The full-year forecast for the fiscal year ending September 2027 assumes revenue of 7,000 million yen, operating income of 2,400 million yen, and a dividend per share of 10.50 yen. Because results for FY2026 came in above prior projections, the dividend will be increased from 9.0 yen to 9.5 yen. Under the Kanamic Vision 2035 framework, the company targets medium‑ to long‑term revenue of 20,000–30,000 million yen and operating income of 8,000–12,000 million yen, aiming to balance growth investments with shareholder returns.